Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on modern management of frailty

LIVE: Thursday 17th October 2024, 18:00-19:30 (CEST)

Frailty has a significant impact on health and wellbeing, especially in older adults. Join our experts to understand the factors that contribute to the development of frailty and find out how to manage the condition and reduce the risk of disability, dependency, and mortality.
ADVANCED SEARCH
Log in
Top

Current Hypertension Reports

Issue 1/2024

Content (4 Articles)

  • Open Access
  • Hypertension
  • Antihypertensive Agents: Mechanisms of Drug Action (M Ernst, Section Editor)

Angiotensin Receptor Blockers and Cognition: a Scoping Review

Zhen Zhou, Suzanne G. Orchard, Mark R. Nelson, Michelle A. Fravel, Michael E. Ernst

  • Open Access
  • Hypertension
  • Sleep and Hypertension (SJ Thomas)

Non-Dipping Blood Pressure or Nocturnal Hypertension: Does One Matter More?

Amber Tang, Eugene Yang, Joseph E. Ebinger

Pressure Building Against the Clock: The Impact of Circadian Misalignment on Blood Pressure

Brooke M. Shafer, Sophia A. Kogan, Andrew W. McHill

Salty Subjects: Unpacking Racial Differences in Salt-Sensitive Hypertension

Soolim Jeong, Stacy D. Hunter, Marc D. Cook, Gregory J. Grosicki, Austin T. Robinson

Dec 23
Issue: 12/2023
Feb 24
Issue: 2/2024

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

EASD 2024

‘Noninferior’ reduction of type 1 diabetes HbA1c by weekly insulin efsitora alfa

Weekly treatment with insulin efsitora is noninferior to daily insulin degludec for the reduction of HbA1c in adults with type 1 diabetes, show the findings of the QWINT-5 trial.

Read more

Weight loss with new obesity drug amycretin

Tirzepatide significantly reduces UACR in individuals with obesity and type 2 diabetes

Liraglutide reduces BMI for young children with obesity

» View more highlights on the EASD 2024 hub page

2024 ESC Congress

Noise pollution dangerous for heart health

Two studies underscore the adverse impact of noise pollution on the risk for and prognosis after myocardial infarction.

Read more

Post-TAVI follow up: deploying virtual assistants

Antihypertensives: more effective at morning or night?

Low Lp(a) levels unlikely to increase the risk of diabetes

» View more highlights on the 2024 ESC Congress hub page

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more
Image Credits